Persistent Increase in Serum Ferritin Levels despite Converting to Permanent Vascular Access in Pediatric Hemodialysis Patients: Pediatric Nephrology Research Consortium Study
Authors:
- Ali Mirza OnderAOAli Mirza Onder
- Abu Yusuf AnsariAAAbu Yusuf Ansari
- Fang DengFDFang Deng
- Matthew M. GrinsellMGMatthew M. Grinsell
- Larry PattersonLPLarry Patterson
- Jennifer JettonJJJennifer Jetton
- Sahar Fathallah-ShaykhSFSahar Fathallah-Shaykh
- Daniel RanchDRDaniel Ranch
- Diego AvilesDADiego Aviles
- Lawrence CopelovitchLCLawrence Copelovitch
- Eileen EllisEEEileen Ellis
- Vimal ChadhaVCVimal Chadha
Open Access
- 25 June 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (13) , 4251
Abstract
Our objective was to examine serum ferritin trends after conversion to permanent vascular access (PVA) among children who started hemodialysis (HD) using tunneled cuffed catheters (TCC). Retrospective chart reviews were completed on 98 subjects from 20 pediatric HD centers. Serum ferritin levels were collected at the creation of PVA and for two years thereafter. There were 11 (11%) arteriovenous grafts (AVG) and 87 (89%) arteriovenous fistulae (AVF). Their mean TCC use was 10.4 ± 17.3 months. Serum ferritin at PVA creation was elevated at 562.64 ± 492.34 ng/mL, increased to 753.84 ± 561.54 ng/mL (p = < 0.001) in the first year and remained at 759.60 ± 528.11 ng/mL in the second year (p = 0.004). The serum ferritin levels did not show a statistically significant linear association with respective serum hematocrit values. In a multiple linear regression model, there were three predictors of serum ferritin during the first year of follow-up: steroid-resistant nephrotic syndrome as primary etiology (p = 0.035), being from a center that enrolled >10 cases (p = 0.049) and baseline serum ferritin level (p = 0.017). Increasing serum ferritin after conversion to PVA is concerning. This increase is not associated with serum hematocrit trends. Future studies should investigate the correlation of serum transferrin saturation and ferritin levels in pediatric HD patients.Keywords
This publication has 37 references indexed in Scilit:
- Trends in anemia management in US hemodialysis patients 2004–2010BMC Nephrology, 2013
- Management of anemia with erythropoietic-stimulating agents in children with chronic kidney diseasePediatric Nephrology, 2013
- Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapyPediatric Blood & Cancer, 2010
- Ferritin for the clinicianBlood Reviews, 2009
- Serum Ferritin Level Remains a Reliable Marker of Bone Marrow Iron Stores Evaluated by Histomorphometry in Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2009
- Combined High Serum Ferritin and Low Iron Saturation in Hemodialysis PatientsClinical Journal of the American Society of Nephrology, 2008
- Clinical predictors of neurocognitive deficits in children with chronic kidney diseasePediatric Nephrology, 2007
- Ferric Gluconate Is Highly Efficacious in Anemic Hemodialysis Patients with High Serum Ferritin and Low Transferrin SaturationJournal of the American Society of Nephrology, 2007
- II. Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease in AdultsAmerican Journal of Kidney Diseases, 2006
- Epoetin requirements predict mortality in hemodialysis patientsAmerican Journal of Kidney Diseases, 2004